Case File
efta-02469724DOJ Data Set 11OtherEFTA02469724
Date
Unknown
Source
DOJ Data Set 11
Reference
efta-02469724
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Dangene and Jennie Enterprise
Sent:
Wednesday, February 24, 2016 12:46 PM
To:
Jeffrey Epstein
Subject:
Re: thanks for the email earlier
YES !
CORE: Jennie Enterprise I
Founder & Chairman I 66 East 55th Street New York NY 10022 I
mailto
I www.coreaccess.net
chttp://www.coreaccess.net/> I
On Feb 24, 2016, at 7:45 AM, jeffrey E. <[email protected] <mailto:[email protected]» wrote:
my original idea
On Wed, Feb 24, 2016 at 1:20 PM, Dangene and Jennie Enterprise
<mailto
> wrote:
had a great call with Russ and Nick last night and we all agreed that the best path forward is to creat an
entirely different structure that would accomplish the following - get money to buy rfr out but do it in an entity that
doesn't touch legacy companies and then create some synthetic equity to connect that entity to NY - same result
different mechanism ,,,,one idea that we started to explore between the morning call and the evening call that we ran
by them is the following ( just an example of one way to shape it ...our lawyers are out of the country for meetings over
next few days but we expect to get them something early next week ...also Russ said that they could move quickly on
this because all their tax issues go away ....
a. Jennie & Nathan establish a NewCo (outside the entire TCC universe)
b. TCCI (through TCC IP) signs an agreement with NewCo to grant it a perpetual exclusive license to all
the CORE: IP .
c. Funds flow into TCC IP or TCCI as necessary/required.
d. TCCI upon receipt of the funds, pays RFR/AES as per the terms of the current agreements being
drafted between the parties.
e.
All NY COD related issues are dealt with as appropriate and not subject to the new venture (i.e. in
the best interest of the company and owner (JE))
LOVE YOU
CORE: Jennie Enterprise I
EFTA_R1_01580319
EFTA02469724
Founder & Chairman I 66 East 55th Street New York NY 10022 I
mailto
www.coreaccess.net <http://www.coreaccess.net/>
please note
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
JEE
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected] <mailto:[email protected]> , and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
2
EFTA_R1_01580320
EFTA02469725
Technical Artifacts (4)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.